Silicone phantom validation of breast cancer tumor detection using nominal stiffness identification in digital imaging elasto-tomography (DIET)

Abstract

Abstract Background and objective Cancerous tumors exhibit considerably higher stiffness than healthy breast tissues. This research develops a hysteresis loop analysis detection method for breast cancer diagnosis, which is validated using silicone phantom tests to provide an initial proof of concept of the overall DIET diagnostic approach. Methods Steady state sinusoidal displacements induced by mechanical actuation are captured using the DIET system for 4 silicone breast phantoms (1 homogeneous “healthy”; 3 with 10–20 mm stiffer inclusion “tumors” at different locations). Hysteresis loops for each measured reference point on the breast surface (N≈14,500/phantom) are constructed from the measured displacements and a calculated mass normalized restoring force. The distribution of nominal elastic stiffness over breast surface is estimated using a hypothesis test and regression analysis. A small motion threshold, Δ d , is used to reduce errors in identified elastance and its values determined from sensitivity analysis. Results Sensitivity analysis shows displacement reconstruction errors from very small motions can be eliminated using a threshold Δ d = 6 μ m to clearly reduce errors in identified nominal elastance. Results for all 4 phantoms indicate stiffer inclusions induce a greater number of reference points with stiffness ≥2 × higher in the segment with the inclusion than the nominal stiffness in the “healthy” segments in the x , y and total net 2D displacement directions. Therefore, the presence of a stiffer “tumor” inclusion is automatically detected and located by comparing the nominal stiffness to a calculated threshold, k t . Inclusion segments are finally localized algorithmically using an inclusion indicator, K index . Conclusions The overall results validate the capability of the proposed method to accurately detect and locate a stiff inclusion in typical, representative silicone breast phantoms without misidentifying other regions or a healthy no-inclusion phantom in the non-invasive DIET system. The methods are entirely generalizable to human clinical data from a DIET system, and the results justify such clinical trials.